Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
Michael Praktiknjo,
Antonia Witt,
Filippo Schepis,
Juan Carlos Garcia-Pagan,
Manuela Merli,
Jonel Trebicka
Affiliations
Michael Praktiknjo
Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany
Antonia Witt
Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany
Filippo Schepis
Division of Gastroenterology, Azienda Ospedaliero-Universitaria di Modena and University of Modena and Reggio Emilia, Modena, Italy
Juan Carlos Garcia-Pagan
Hospital Clinic of Barcelona, University of Barcelona, CIBEReHD, IDIBAPS, Barcelona, Spain
Manuela Merli
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
Jonel Trebicka
Department of Internal Medicine I, J.W.Goethe University Hospital, Frankfurt, Germany; European Foundation for Study of Chronic Liver Failure, Barcelona, Spain; Corresponding author. Address: Department of Internal Medicine I, University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany; Tel.: +49 69 6301 4256.
